MedPath

The effect of cyproheptadine on pediatric growth

Not Applicable
Completed
Conditions
Failure to thrive.
Other lack of expected normal physiological development
Registration Number
IRCT201201268827N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

children aged between2 to 5 years old and have mild to moderate failure to thrive.
Exclusion criterion: Having organic causes or acute or chronic diseases.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.